IPS IPSOS

Ipsos successfully completes a bond issuance of €400 million

Ipsos successfully completes a bond issuance of €400 million

Ipsos successfully completes a bond issuance of €400 million

Paris, 15 January 2025 – , one of the world’s leading market research companies, announces the successful issuance of its first rated bond for €400 million. The bond is maturing in January 2030 and carrying a coupon of 3.75%. Ipsos is rated Baa3 with stable outlook by Moody’s and BBB with stable outlook by Fitch.

The very strong investor demand, with an orderbook covering more than 9 times the size of the bond, is a testament to their confidence in Ipsos’ business model and credit profile. This substantial level of oversubscription allowed Ipsos to price the bond with a final spread significantly below initial price indication.

The proceeds will be used for general corporate purposes, including the refinancing of its €300 million existing bond maturing in September 2025.

Disclaimer

This press release is for information purposes only and is not an offer to sell or subscribe securities or a solicitation of an order to purchase or subscribe securities in any jurisdiction. The securities mentioned in this press release were not and will not be offered through a public offering. This press release does not constitute an offer for sale of securities in the United States of America or any other jurisdiction. These securities may not be offered or sold in the United States of America unless they are registered or exempt from the registration requirements of the US Securities Act of 1933, as amended. Ipsos does not intend to register any of the securities mentioned in this announcement in the United States or to conduct a public offering of securities in the United States. This press release is not a prospectus as required under EU Regulation 2017/1129 (the “Prospectus Regulation”). A prospectus will be prepared and made available, in compliance with the Prospectus Regulation, as part of admitting the bonds to trading on the Euronext regulated market Paris. This press release does not constitute an offer of securities in France or in any other country. The bonds will be offered only qualified investors as defined under article 2(e) of the Prospectus Regulation and in accordance with Article L.411-2 of the Monetary and Financial Code. No prospectus related to the placement of the bonds has been approved by a competent authority of a European Economic Area Member State. The dissemination of this press release in any country where such dissemination could constitute a violation of applicable legislation is prohibited.

ABOUT IPSOS

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing nearly 20,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

“Game Changers” – our tagline – summarizes our ambition to help our 5,000 clients navigate with confidence our rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120, Mid-60 indices, and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

35 rue du Val de Marne

75 628 Paris, Cedex 13 France

Tel. 00

Attachment



EN
15/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IPSOS

 PRESS RELEASE

Ipsos strengthens its expertise in Germany with the acquisition of InM...

Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Ipsos strengthens its expertise in Germany with the acquisition of InMoment's Healthcare division Paris, 7 July 2025 - , one of the world's leading market research companies, announces the acquisition of InMoment’s Healthcare division in Germany, enabling to bolster its expertise in this sector and generate further growth opportunities in the country. Ben Page, CEO of Ipsos, stated: “We are pleased to welcome the experienced InMoment German Healthcare team to Ipsos, adding a new competence ce...

 PRESS RELEASE

Ipsos renforce son expertise en Allemagne avec l'acquisition de la div...

Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Ipsos renforce son expertise en Allemagne avec l'acquisition de la division Santé d'InMoment Paris, 7 juillet 2025 - , l’une des principales sociétés mondiales d’études de marché, annonce l'acquisition de la division Santé d'InMoment en Allemagne, lui permettant de renforcer son expertise dans ce secteur et de générer de nouvelles opportunités de croissance dans le pays. Ben Page, Directeur Général d’Ipsos, a déclaré : « Nous sommes heureux d'accueillir l'équipe allemande expérimentée d'InMoment ...

 PRESS RELEASE

Ipsos Strengthens Its Board of Directors

Ipsos Strengthens Its Board of Directors Ipsos Strengthens Its Board of Directors Paris, June 30, 2025 – Ipsos announces the appointment of three new members to its Board of Directors: Ms. Armelle Carminati-Rabasse, Mr. Lionel Chaine, and Ms. Anne-Marie Couderc. The appointments of Mr. Chaine, as the permanent representative of Bpifrance Investissement, and Ms. Carminati-Rabasse follow the votes held at the Company’s Annual General Meeting on May 21, 2025.The Board of Directors, meeting on June 20, 2025, decided to co-opt Ms. Anne-Marie Couderc to replace Ms. Florence Parly, who stepped d...

 PRESS RELEASE

Ipsos renforce son Conseil d’administration

Ipsos renforce son Conseil d’administration Ipsos renforce son Conseil d’administration Paris, le 30 juin 2025 - Ipsos annonce la nomination de trois nouveaux administrateurs au sein de son Conseil : Mme Armelle Carminati-Rabasse, M. Lionel Chaine et Mme Anne-Marie Couderc. La désignation de M. Chaine, en tant que représentant permanent de Bpifrance investissement, et de de Mme Carminati-Rabasse fait suite au vote de l'Assemblée générale de la société le 21 mai 2025. Le Conseil d’administration, réuni le 20 juin 2025, a décidé de coopter Mme Anne-Marie Couderc, en remplacement de Mme Flo...

 PRESS RELEASE

Ipsos: Monthly declaration of shares and voting rights - May 2025

Ipsos: Monthly declaration of shares and voting rights - May 2025 June 27, 2025 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF Date   Shares   Voting rights Theoretical* Exercisable** 31 May 2025 43,203,225 48,990,941 48,941,337 *This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch